AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
BreastCarcinoma, Ductal, BreastBreast DiseasesBreast FeedingBreast Neoplasms, MaleReceptors, EstrogenMammographyFibrocystic Breast DiseaseCell Line, TumorBreast ImplantsBreast Self-ExaminationReceptor, erbB-2Receptors, ProgesteroneTamoxifenGene Expression Regulation, NeoplasticMastectomyCarcinoma, Intraductal, NoninfiltratingPrognosisTumor Markers, BiologicalCarcinoma, LobularRisk FactorsNeoplasm InvasivenessUltrasonography, MammaryNeoplasm MetastasisCase-Control StudiesAntineoplastic Agents, HormonalGenes, BRCA1Lymphatic MetastasisNeoplasm StagingPostmenopauseImmunohistochemistryMilk, HumanTumor Cells, CulturedMastectomy, SegmentalMammaplastyBreast CystTime FactorsCarcinomaChemotherapy, AdjuvantNeoplasm ProteinsEstrogensPremenopauseAntineoplastic AgentsMCF-7 CellsMammary Glands, HumanFibroadenomaEstrogen Receptor alphaNipplesMammary Neoplasms, ExperimentalFollow-Up StudiesMenopauseBreast ImplantationBRCA2 ProteinTreatment OutcomeBRCA1 ProteinAxillaProspective StudiesCell ProliferationGenes, BRCA2Mass ScreeningNeoplasms, Hormone-DependentCohort StudiesAge FactorsIncidenceTriple Negative Breast NeoplasmsInflammatory Breast NeoplasmsGenes, erbB-2Carcinoma, DuctalGenetic Predisposition to DiseaseNeoplasm Recurrence, LocalRetrospective StudiesAromatase InhibitorsEstrogen AntagonistsDisease-Free SurvivalSurvival AnalysisCarcinoma in SituGene Expression ProfilingRiskMice, NudeEstradiolAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmRisk AssessmentRNA, MessengerSensitivity and SpecificityQuestionnairesBiopsy, NeedleReverse Transcriptase Polymerase Chain ReactionOdds RatioSignal TransductionMultivariate AnalysisReproducibility of ResultsSurvival RateMastectomy, Modified RadicalDisease ProgressionDNA, NeoplasmLogistic ModelsUnited StatesSurvivorsProportional Hazards Models